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The study involves cross-sectional analyses of 44,957 veterans and non-veterans
enrolled in Medicare. Merged Medicare claims for fee-for service enrollees and
survey data from multiple years of the Medicare Current Beneficiary Survey from
2001 through 2005. ACSH for thirteen conditions were identified using inpatient
Medicare claims and an algorithm developed by the Agency for Healthcare Quality,
which uses International Classification of Diseases, 9th edition codes. Dual use was
defined as having inpatient or outpatient visits to the VHA and consisted of pre-
dominant-VHA use and some VHA use. Unadjusted group differences in any ACSH
were tested using chi-square tests. Logistic regressions were used to analyze the
association between dual VHA use and ACSH after controlling for demographic,
socio-economic, health status, mental illness, smoking and obesity. All analyses
accounted for the complex design of the survey. RESULTS: The three most com-
mon ACSH were congestive heart failure, bacterial pneumonia, and chronic ob-
structive pulmonary disease. Among inpatient users, 10.1% had ASCH for acute
conditions and 15.8% for chronic conditions. Among all survey respondents, 5%
had any ACSH; the rates were 4.9% for VHA users and 3.7% for veterans with some
VHA use. In bivariate and multivariate analyses, dual use was not significantly
associated with any ACSH. CONCLUSIONS: In a representative sample of Medicare
beneficiaries, ACSHwere prevalent. Despite poor health status, dual VHA/Medicare
use was not associated with increased ACSH rates perhaps due to the provision of
good primary care in the VHA system.
PIH38
EPIDEMIOLOGY OF ADOLESCENT AND YOUNG ADULT HOSPITAL UTILIZATION
FOR ALCOHOL AND DRUG USE, SUICIDE, AND POISONING IN THE UNITED
STATES
Barnard M, Banahan BF
University of Mississippi, University, MS, USA
OBJECTIVES: Adolescence and young adulthood are an important transitional pe-
riod during which morbidity and mortality often arise from individual’s behaviors
such as alcohol and drug use, suicide, and poisonings. Self-report survey data
regarding health behaviors are readily available, however little data from objective
sources has been reported and minimal study of health care utilization, particu-
larly hospital utilization, related to these behaviors has been conducted. This study
examines the patterns and characteristics of individuals admitted to the hospital
for these conditions.METHODS: The data for this investigation came from the 2007
National Hospital Discharge Survey (NHDS). Records for all individuals who had an
age in the range of 10-24 years and were discharged from the hospital with any
recorded diagnosis of alcohol or drug abuse or dependence, suicide, or poisonings
were abstracted. National estimates were calculated utilizing the weighted num-
ber of discharges and the U.S. Census Bureau population data for this age group.
Rao-Scott Chi square tests were performed to evaluate differences between groups
and all significance tests were two-sided using p0.05 as the level of statistical
significance. RESULTS: National estimates for hospital discharges per 1,000 10-24
year olds are 54.2 for alcohol/drug use, 3.3 for suicide, and 9.8 for poisoning. Sea-
sonal trends in alcohol/drug and suicide discharges were observed, as were re-
gional differences with more than twice as many alcohol/drug-related discharges
in the South. Over 42% of all care related to these diagnoses is expected to be paid
for by public health insurance programs. Self-pay is also high for these conditions
(16.1%). CONCLUSIONS: A significant porition of inpatient hospital care for adoles-
cents and young adults is attributable to alcohol/drug use, suicide, and poisonings.
These data have implications for primary intervention programs and suggest the
need for further investigation of the associated health care costs related to these
conditions.
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OBJECTIVES: Electronic-medical-record (EMR) systems have the potential for im-
proving the quality of preventive healthcare forwomen, by reminding patients and
physicians to obtain appropriate screenings and vaccinations, and decrease
health-care costs significantly by preventing emergency-department visits and
hospitalizations. The objective was to study the effect of EMR-system sophistica-
tion on women’s healthcare in physician offices. METHODS: The National Ambu-
latory Medical Care Survey (NAMCS), a cross-sectional database of physicians’ of-
fice-based visits was analyzed. Based on several of the NAMCS questions, EMR-
systems were classified into nonexistent, minimal, basic, and fully functional
systems according to their set of specific functions. Visits were selected provided
that (1) they were made by a woman  18 years old and (2) the visit was not for a
chronic or acute illness as identified by the visit’s ICD-9 code. Preventive health-
care provision included screenings (mammography and bone-mineral-density im-
aging); exams (breast and pelvic); tests (PAP tests and tests for chlamydia, choles-
terol, and blood pressure); and vaccinations. Estimated frequencies of preventive
health services ordered or completed by the physician were for the four levels of
EMR-system sophistication. RESULTS: In 2007-08, 341,729 physicians ordered or
provided 2.56, 1.31, 1.97, and 1.82million preventive healthcare exams, screenings,
tests, and vaccinations for women aged 18-39, 40-49, 50-64, and 65, respectively.
The ratios of number of preventive women’s healthcare measures to number of
visits bywomen, for practiceswith no EMRwere the lowest (1.12, 1.21, 1.25 and 0.28
for age-groups 18-39, 40-49, 50-64, and 65, respectively). Whereas, practices with
fully-functional EMR systems had the highest ratios, (1.5, 1.54 and 0.48 for age-
groups 18-39, 50-64 and65, respectively), except for the 40-49 age group, forwhich
minimal-EMR-system practices had the highest ratio of 1.61. CONCLUSIONS: Evi-
dence suggests that the more sophisticated the EMR system, the greater the inten-
sity of preventive healthcare service provided to women.
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OBJECTIVES: Assess real world treatment patterns, health care utilization, and
costs of HMB patients. METHODS: Data were administrative claims from a large
national US health plan. Female plan enrollees aged 18-49 with at least 2 claims of
HMB (ICD-9-CM 626.2, 627.0) within 180 days during 01-01-04 to 02-29-08 were
included; index date was initial HMB claim. Continuous enrollment required 6mos
pre-index and 18mos post-index. Patientswere classified as idiopathic HMBunless
underlying conditions associated with HMB occurred in pre-index or 60 days post-
index date. All variables were analyzed descriptively. Multivariate analyses were
conducted to evaluate the factors associated with follow-up HMB-related costs.
RESULTS: Mean [SD] age of the study population (N21,239) was 39.5 [6.8]; mean
[SD] comorbidity score was 0.14 [0.42]. Of the 21,239 women, 57.6% had 1 treatment
episode, 15.7% had 2 or more, and 26.6% had no treatment during the post-index.
15,582 patients received treatment, the distribution of initial treatment was 36.4%
received medication (oral contraceptive [OC], non-OC, or oral medroxyprogester-
one acetate [MPA]), 50.8% had endometrial ablation [EA], and 12.6% underwent
hysterectomy. Mean [SD] HMB-related costs of single episode paths were: hyster-
ectomy $8,656.84 [$5,453.34]), EA $4,579.63 [$3,509.16], and no treatment $616.23
[$946.73]. On average follow-up HMB-related costs are expected to be 9.67 times
greater for womenwithmultiple episodes and 6.33 times greater for single episode
(ref. group: no treatment). Age, Charlson comorbidity score, geographical region
were also associated with higher total follow-up HMB-related costs whereas base-
line OC use and pregnancy during the follow-up lowered costs. CONCLUSIONS:
HMB has significant clinical and economic impact. Over 1/4 of patients did not
receive treatment. Prevalence of surgical procedures was high among those
treated, often constituting first-line treatment. Surgical procedures and multiple
treatment episodes were associated with higher HMB-related costs.
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OBJECTIVES: Patients with unmet expectations for the time required to experience
improvement (or sustained improvement) with treatment may prematurely dis-
continue otherwise effective treatment. We assessed median time to successful
sexual intercourse (SSI) with sildenafil and placebo. METHODS: Successful sexual
intercourse was assessed in an 8-week, double-blind, placebo-controlled trial of
sildenafil treatment in men with erectile dysfunction. SSI for each episode of sex-
ual activity was defined by patient report and by two events: 1) the subject at-
tempted sexual intercourse and 2) the subject had an erection lasting long enough
for successful intercourse. Median time to SSI was calculated for two types of
events: 1) time to the first SSI (transient event) and 2) stable SSI (initial improve-
ment sustained for the remainder of the double-blind 56-day study, defined as at
least 50% of sexual intercourses being successful until the end of the study). Log-
rank tests compared time-to-event curves between treatment groups.RESULTS:Of
288 men enrolled, 95 received placebo, 99 received sildenafil 100 mg, and 94 re-
ceived sildenafil 50 mg. Median time from the start of the study to achieve initial
SSI was 3 days for each group of sildenafil-treated patients (50 mg and 100 mg),
compared with 13 days for placebo-treated patients (P0.001). (Note that not ev-
eryone attempted sexual intercourse on the first day of treatment.) Median time to
achieve stable (sustained) SSI was 5 days (50 mg) and 3 days (100 mg) for sildenafil-
treated patients versus 55 days for placebo-treated patients (P0.001).
CONCLUSIONS: This novel application of time-to-event analysis provides useful
timeframes for when patients can expect to see initial and then stable improve-
ments with sildenafil treatment. Median times to initial SSI and sustained SSI were
significantly shorter for sildenafil-treated vs placebo-treated men.
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OBJECTIVES: Effective treatment of bleedings in hemophiliac patients is important
for limiting costs associated with bleedings and for improving health outcomes.
Two health outcomes of interest is the time from treatment initiation to bleeding
resolution and the probability of developing re-bleedings. The objective of this
study was to develop a methodology with NBF instead of the ICER for estimating
the health economic benefits of a novel treatment with certain characteristics
compared to rFVIIa and to identify the major determinants of the net monetary
benefit of the novel treatment. METHODS: Data from a medical chart review on
hemophilia inhibitor patients in Turkey were used to identify predictors of the
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